Terremoto Biosciences
Latest round
- Series C
Last raised
- Apr 2026
Total raised
- $291M
Investors
- 10
About Terremoto Biosciences
Based in California, US, and founded in 2021 by its CEO, Peter Thompson, and co-founders Matthew Jacobson and Jack Taunton, Terremoto Biosciences Inc. operates as a biotechnology company that leverages lysine-based covalency to develop optimized medicines. In April 2026, Terremoto Biosciences Inc.'s lysine-targeted covalency platform discovers and develops drugs that covalently bind to lysine, an amino acid that is ubiquitous across the proteome and present in nearly every protein of interest. While the abundance of lysine has previously prevented the field from developing medicines that are sufficiently selective and targeted. The platform utilizes structure-based drug design, screening platform development, cryo-electron microscopy, X-ray crystallography, electrophilic warhead library development, and a computational discovery engine.
Who invested in Terremoto Biosciences
10 investors across 3 rounds
See all investors in Terremoto Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Terremoto Biosciences
Who invested in Terremoto Biosciences?
Terremoto Biosciences has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Terremoto Biosciences raised?
Terremoto Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Terremoto Biosciences last raise money?
Terremoto Biosciences's most recent round on record is a Series C, in Apr 2026.
What does Terremoto Biosciences do?
Based in California, US, and founded in 2021 by its CEO, Peter Thompson, and co-founders Matthew Jacobson and Jack Taunton, Terremoto Biosciences Inc.
Where is Terremoto Biosciences headquartered?
Terremoto Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like Terremoto Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Terremoto Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Terremoto Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.